Trial Profile
Phase I Study of Intrathecal Mafosfamide
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2014
Price :
$35
*
At a glance
- Drugs Mafosfamide (Primary)
- Indications Lymphomatous meningitis; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 23 Dec 2008 New trial record.